Literature DB >> 31311046

[Chronic Back Pain, Cervicothoracic Myeolopathy and weight loss - a case report of an IgG4-related disease].

David Kiefer1, Uta Kiltz1, Jürgen Braun1.   

Abstract

HISTORY: A 68-year-old woman presented with chronic back pain, a poor general condition, weight loss of 20 kg in the last 6 months and paretic hands. FINDINGS AND DIAGNOSIS: The patient had pareses of hand- and finger muscles on both sides with corresponding deficits proven by EMG. MRI revealed an intraspinal mass affecting the cervical and thoracic spine with myelon compression. Histologically IgG4-positive plasma cells were detected and IgG4-RD with spinal pseudotumor and resulting cervicothoracic myelopathy were diagnosed. THERAPY AND COURSE: After initiation of high-dose glucocorticoid therapy (100 mg i. v. over 7 days with reduction afterwards) and cyclophosphamide-pulse-therapy (initially 750 mg i. v., cumulative dose of 4500 mg in 6 months), the general condition and motor deficits improved.
CONCLUSIONS: The CNS are a rare manifestation of IgG4-RD. The tumor typically grows displacing, is best visualized on MRI or PET-CT, presenting clinically the corresponding pain and neurological deficits and shows characteristic histology. Steroids and, as in our case helpful, advanced immunosuppression can be a promising treatment option. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31311046     DOI: 10.1055/a-0850-0600

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

Review 1.  Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.

Authors:  Aigli G Vakrakou; Maria-Eleptheria Evangelopoulos; Georgios Boutzios; Dimitrios Tzanetakos; John Tzartos; Georgios Velonakis; Panagiotis Toulas; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Leonidas Stefanis; George E Fragoulis; Constantinos Kilidireas
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.